RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

The University of Cambridge–based DioSynVax and Singapore's ACM Biolabs have signed a deal to jointly develop a ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

The candidate mRNA design applies a unique technology resulting in an in-vivo self-assembly of a protein nanoparticle with clustering of FimH antigen on its surface, which has shown superior ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...